Abstract:Aim: To investigate the changes in expression of connective tissue growth factor (CTGF) of mesangial cells in homoamino acid, and the interventional effect of the advanced glycation end products (AGEs) aminoguanidine on it. Methods: The experiment was conducted in the Laboratory of Nephrology of Tongji Hospital between April and October 2005. (1) Rat mesangial cells were donated by Professor Mei of Shanghai Changzheng Hospital. Amino acid compound injection (The trade name was Lefanming, manufactured by Huarui Pharmaceutical Co., Ltd with the batch number of 041203701); L-arginine (provided by Shanghai Shenggong Bioengineering Technology Service Co., Ltd. with the batch number of 0421S04); Aminoguanidine (Germany). (2) The CTGF mesangial cells in the logarithmic phase were obtained according to the growth curve of intercapillary cells cultured by the Laboratory before, and cells were routinely inoculated into 6 bottles at the density of 1×10 5. Samples were divided into 3 groups after 60%-80% of the bottle was covered: low glucose group (group A), homoamino acid plus low glucose group (group B) and aminoguanidine plus homoamino acid plus low glucose group (group C) with two bottles in each group. (3) Cells in three groups were cultured under different condition. Samples in group A were cultured with 5.5 mmol/L of DMEM of normal glucose. Samples in group B were cultured with 5.5 mmol/L of DMEM of normal glucose plus 8.5% amino acid compound injection and 2.48 mmol/L L-arginine; Samples in group C were treated the same with those in group B, besides, 0.5 mmo/L aminoguanidine was added. (4) The expression of mRNA in CTGF was examined by reverse transcription-polymerase chain reaction (RT-PCR) after treatment for 24 hours, and Western-blot analysis was used to assay the CTGF protein level after treatment for 48 hours. The detection was repeated for three times under the same condition. Results: (1) The expression of CTGF mRNA expression in three groups at 24 hours after culture: It was significantly higher in group B than that in group A (1.895±0.142,0.564±0.238,P < 0.05), while that in group C decreased to 0.882±0.189, which was remarkably lower than that in group B (P < 0.05). (2) The CTGF expression in each group at 48 hours after culture: It was significantly higher in group B than that in group A [(2.125±0.271)×10 5, (1.125±0.104)×10 5, P < 0.05], while that in group C decreased to (1.391±0.193)×10 5 after adding into the aminoguanidine, which was significantly lower than that in group B (P < 0.05), and it was similar to that in group A (P > 0.05). Conclusion: Homoamino acid can induce large amount of CTGF expression in mesangial cells, while aminoguanidine can significantly inhibit the expression, which indicate that there are correlation between the increased expression of CTGF induced by homoamino acid and AGEs.

Effect of advanced glycosylation end products on connective tissue growth factor in rat kidney

Induction of connective tissue growth factor mRNA expression by advanced glycosylation end products in cultured rat renal mesangial cells

AGEs Increased Migration and Inflammatory Responses of Adventitial Fibroblasts Via RAGE, MAPK and NF-κB Pathways

Effect of Advanced Glycosylation End Products on Expression of Tissue Transglutaminase Mrna in Rat Proximal Tubular Epithelial Cells

Advanced Glycation End Products Upregulates The Expression Of Connexin43 Via Erk Mapk And Pi3k/Akt Pathways In Human Endothelial Cells

Effects of Advanced Glycation End Products on Insulin-Like Growth Factor-1 Expression in Rat Mesangial Cells

Pattern of CTGF mRNA expression induced by advanced glycation end products in mesangial cells

Effects of Advanced Glycation End Products on Expression and Activity of PAI-1 in Rat Renal Cortex

Effect of advanced glycosylation end products on expression of connective tissue growth factor in mouse embryo fibroblasts

Effect of advanced glycosylation end products on expression of connective tissue growth factor in cultured rat aortic smooth muscle cells

Effects of Advanced Glycation End Products on Activity and Expression of Matrix Metalloproteinase-2 in Renal Cortex of Rats

TGF-β and CTGF Expression Induced by Advanced Glycation End Products is Ameliorated by GBE

Expression of mesangial cell derived connective tissue growth factor in homoamino acid and the inhibitory effect of aminoguanidine

Effects of Advanced Glycation End Products on the Expression of Plasminogen Activator Inhibitor-1 in Rat Mesangial Cells

Advanced Glycation End-Products Induce Tubular CTGF Via TGF-beta-independent Smad3 Signaling.

Effects of glycyrrhizic acid on glomerular mesangial cells and ECM expression induced by AGEs

Effect of Advanced Glycation End Products on Expression of Urotensin II and G-Protein-Couple Receptor mRNAs in Rat Mesangial Cells

Effects of Advanced Glycation End Products on the Mrna Expression of Urotensin II and G Protein-Coupled Receptor in Rat Mesangial Cells

Effects of PPAR-γ Activation on Rat Mesangial Cell Extracellular Matrix Accumulation Induced by Advanced Glycation End Products

Effects of advanced glycation end products on the expression of urotensin Ⅱ in rat NRK-52E cells

Effects of Advanced Glycosylation End Products on Proliferation and Cytosolic Free Calcium in Cultured Rat Aortic Smooth Muscle Cells